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The production and characterization of recombinant antibodies to aflatoxin B1 (AFB1), a
potent mycotoxin and carcinogen is described. The antibody fragments produced were then
applied for use in a surface plasmon resonance-based biosensor (BIAcore), which measures
biomolecular interactions in ‘real-time’. Single chain Fv (scFv) antibodies were generated to
aflatoxin B1 from an established phage display system, which incorporated a range of
different plasmids for efficient scFv expression. The scFv’s were used in the development of
a competitive ELISA, and also for the development of surface plasmon resonance (SPR)-
based inhibition immunoassays. They were found to be suitable for the detection of AFB1, in
this format, with the assays being sensitive and reproducible.
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INTRODUCTION
Aflatoxins were discovered in 1960 following the deaths of several thousand turkey poults
throughout England, due to consumption of contaminated Brazilian groundnut meal (Murray
et al., 1982). They are a group of highly toxic fungal secondary metabolites that occur in
Aspergillus species (O’Kennedy & Thornes, 1997). The fungus contaminates foodstuffs and
feeds, as well as crops such as maize, cottonseed, peanuts, and tree nuts during growth but
particularly while in storage. Contamination is most common in tropical and sub-tropical
countries where humidity is high, and, therefore, allows favourable conditions for the fungus
to grow. Aflatoxins are members of the coumarin family and the most significantly occurring
compound is aflatoxin B1 (AFB1), which is produced by certain strains of Aspergillus flavus
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and Aspergillus parasiticus. Other aflatoxins designated B2, G1, and G2 are also produced,
but AFB1 is generally present in the largest quantity, and is the most toxic. Aflatoxin M1
(AFM1-or 4-hydroxy-AFB1) is a hydroxylated metabolite of AFB1, which is excreted in the
milk of dairy cattle after they consume aflatoxin-contaminated food. AFB1 is a very potent
carcinogen and has been linked to human hepatocellular carcinoma. The international agency
for research on cancer regards it as a human carcinogen (Ward et al., 1990).
Due to the widespread occurrence of the toxin-producing fungi in cereals, major efforts
have been made to develop rapid and sensitive methods for detection of aflatoxins. Thin-
layer chromatography and high-pressure liquid chromatography have been traditional
methods used (Nawaz et al., 1995), but can lack sensitivity and consistency due to the
presence of many components in food and biological matrices that can interfere with
physiochemical analysis. Immunoassays can offer high levels of sensitivity and specificity,
and are capable of high sample throughput (Linskens et al., 1992). Due to the low molecular
weight of aflatoxin B1 (i.e. less than 1000 Da) it must be covalently linked to an
immunogenic carrier molecule such as a protein (e.g. bovine serum albumin; BSA), which
will elicit a strong immune response following immunization. The protein conjugate is also
used at the screening and characterization stages of antibody production.
Antibody engineering has allowed for the construction of large antibody libraries that can
be used for the in vitro selection of many different molecules. In recent years, phage-display
technology has also become increasingly powerful, and has transformed the way in which we
produce binding-ligands, such as antibodies or peptides for a given target. In order to produce
a recombinant antibody phage display library, mice were immunized with AFB1-BSA
conjugate, and the RNA from their spleens was used for the construction of an antibody
phage-display library, which was used to produce soluble scFv antibodies specific for AFB1.
One of the main advantages of phage-display technology is the direct link of DNA sequence
to protein function. As a result, single clones can be rapidly screened for antigen binding, as
well as being selected from pools in the same experimental set-up. A new and re-designed
phage display system has been developed by Krebber et al. (1997), which has a number of
significantly improved features that include an extended primer mix for amplification of the
variable heavy and light chains, directional cloning of the scFv fragment using the restriction
enzyme SfiI, as well as a number of vectors that allow for expression of the scFv in various
forms.
The genetic material (mRNA) for use in an antibody phage display library can originate
from an immunized mouse if one were to produce a pre-immunized phage display library, or
alternatively a naı¨ve mouse for production of a naı¨ve library. It is also possible to obtain the
genetic material from a hybridoma, and clone the scFv fragment of the parent monoclonal
antibody (MAb). The mRNA is then reverse-transcribed to produce DNA. The VH and VL
fragments are amplified by PCR using the designated primers and the DNA. In the Krebber-
based system, splice by overlap extension (SOE)-PCR is used to anneal the VH-VL fragments
together as one. Restriction enzyme digestion is carried out on the SOE product as well as
the vector (pAK 100), which enables ligation of the scFv fragment into pAK 100. This is
transformed into E. coli, and results in an antibody phage display library. Once the bacteria
are harbouring the phagemid vector, they can be superinfected with helper phage to drive
production of phage particles carrying the scFv fragment, as a fusion product with the phage
coat protein pIII on the surface and genes encoding the scFv inside the particle. Expression
of the fusion product and its subsequent incorporation into the mature phage coat results in
the ligand being presented on the phage surface, while its genetic material resides within the
phage particle. This connection between ligand genotype and phenotype allows the
enrichment of specific phage using selection on an immobilized target.
The single chain Fv antibodies produced, were applied in a biosensor system called
biospecific interaction analysis (BIA). This is able to measure biospecific interactions (e.g.
antigen–antibody binding) in ‘real-time’. A commercially available instrument (BIAcore)
works on the principle of surface plasmon resonance (SPR) (Quinn & O’Kennedy, 1999). It
PRODUCTION AND CHARACTERIZATION OF MURINE SINGLE CHAIN Fv ANTIBODIES 257
detects changes in the refractive index continuously of an antibody and free toxin solution
close to the surface of the sensor chip. Aflatoxin conjugate is covalently immobilized onto the
surface of the sensor chip and scFv antibody and free toxin is allowed to flow continuously
over the surface. The conjugate and free toxin in solution compete for binding to the scFv
antibody in solution. As the scFv binds to the conjugate, the refractive index of the buffer in
contact with the sensor chip changes. The change in refractive index is measured by SPR.
Continuous monitoring of the resonance angle gives a change in the refractive index of the
buffer solution close to the metal film surface. This change is then detected and quantified
(as response units) by the instrument as a sensorgram. Approximately 1000 response units
(RU) is equivalent to a mass change in the surface concentration of 1 ng mm–2 (Stenberg et
al., 1991). After the binding interaction occurs, the bound antibody can be removed using
chaotrophic reagents, which allow the sensor surface to be used repeatedly. BIAcore has been
used for applications such as kinetic analysis (Marlborg & Borrebaeck, 1995), inhibition
immunoassays for the detection of small molecules such as drugs and pesticides (Wagner et
al., 1995; Alcocer et al., 2000; Dillon et al., 2003), as well as proteomic applications (Krone
et al., 1997; Nelson et al., 2000). It has also been previously been used in the detection of
mycotoxins (Van der Gaag et al., 1998), where aflatoxin B1 was directly immobilized onto
the dextran gel surface for use in an inhibitive immunoassay. It was found that the assay was
sensitive enough for detection of aflatoxins in food and feed. SPR-based immunoassays have
also been developed for other mycotoxins, such as fumonisin B1 (Mullett et al., 1998).
The research described in this paper focuses on the exploitation of phage display
technology for the production of murine single chain Fv antibodies to aflatoxin B1 using the
‘Krebber’-based system (Krebber et al., 1997). Soluble single chain Fv antibodies were
isolated from the library, were characterized and subsequently used for the quantification of
free aflatoxin, using an inhibitive indirect sensing method on BIAcore.
MATERIALS AND EQUIPMENT
Caution. Aflatoxin B1 is carcinogenic and should be handled with extreme care.
All reagents and chemicals were supplied by Sigma Chemical Co. (Poole, Dorset, UK),
unless otherwise stated. Carboxy-methylated dextran was obtained from Fluka Chemicals
(Gillingham, Dorset, UK) BIAcore 3000™ and CM5 sensor chip were both supplied by
BIAcore AB (Uppsala, Sweden).
Immunization Protocol for BALB/c Mice for the Production of scFv Anti-aflatoxin
B1 Antibodies From Splenomic RNA
A stock 5 mg ml–1 solution of aflatoxin B1-BSA (AFB1-BSA) conjugate was prepared in
phosphate-buffered saline solution (PBS, pH 7.3, 0.15 M-NaCl). This was diluted to a
concentration of 50 g ml–1 in PBS. An equal volume of Freund’s Complete adjuvant was
added to 50 g ml–1 of the conjugate. The mixture was vortexed until it formed an emulsion.
6–10-week-old BALB/c mice were injected sub-cutaneously with 250 l of the immunogen
at several sites. On day 21, the mice were re-immunized intraperitoneally with the same dose
of immunogen and Freund’s Incomplete adjuvant. On day 28 a blood sample was taken from
the tail and analysed, along with intraperitoneal boosts. Subsequent blood sampling was
continued until a satisfactory titre of greater than or equal to 1/50 000 was obtained. 3–4 days
prior to being sacrificed, the mice were injected with 250 l of 50 g ml–1 AFB1-BSA
conjugate in PBS. This was administered intravenously via the tail vein.
Production of a Single Chain Fv Antibody Library to Aflatoxin B1
A pre-immunized scFv phage display library was produced according to the method
described by Krebber et al. (1997). Total RNA was extracted from spleen cells using Trizol
Reagent. This is a ‘ready-to-use’ reagent for the isolation of total RNA from cells and tissues,
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based on the procedure of Chomczynski & Sacchi (1987) 7–10 g of total RNA was reverse
transcribed, using random hexamer primers (Promega) to produce cDNA.
For amplification of VL and VH antibody genes from total RNA, PCR reactions were
performed in 50 l volumes, containing 6–8 g of cDNA, 0.1 nmol of L Back (LB) and L
Forward (LF) primer mixes for amplification of VL genes or 0.1 nmol of HB and HF primer
mixes for amplification of VH genes, 0.4 mM-dNTPs with 1.0 mM-MgCl2 used with the
reaction buffer supplied by the manufacturers. PCR purification of both the VH and VL genes
was performed using the Wizard PCR prep DNA purification kit (Promega) followed by
assembly into the scFv format using a 20 amino acid linker by SOE-PCR, with minor
modifications.
The SOE-PCR products were again gel purified, SfiI digested and ligated following the
manufacturers instructions (Promega) into the pAK100 vector (kindly donated by Dr A.
Plu¨ckthun, Universita¨t Zu¨rich, Switzerland). This was followed by electroporation into E.
coli XL1-Blue supercompetent cells (Stratagene).
For expression of phage display antibodies, 50 ml of non-expression medium (NE) (2 × TY
containing 1% (v/v) glucose and 25 g ml–1 chloramphenicol) was inoculated with 109 cells
from the library glycerol stocks and grown in a shaking incubator at 250 rpm at 37°C until
the optical density at 550 had reached 0.5 AU. 1011 VCSM13 helper phage (Stratagene) and
25 l of 1 M-isopropyl--D-thiogalactopyranoside (IPTG) were added and after incubation at
37° C for 15 min without agitation, the culture was diluted with 100 ml of low expression
medium (LE) (2 × TY containing 1% (v/v) glucose, 25 g ml–1 chloramphenicol and
0.5 mM-IPTG). The culture was shaken (250 rpm) for 2 h at 26°C followed by addition of
30 g ml–1 of kanamycin. The culture was then allowed to continue shaking at 26°C for a
further 8 h. Phage particle precipitation was then carried out using PEG/NaCl and the pellet
resuspended in 2 ml of sterile PBS.
Screening for scFv Phage Display Antibodies From a Pre-immunized Anti-AFB1
Phage Display Library
Synthesis of AFB1-dextran conjugate. This procedure was performed according to Langone
and Van Vunakis (1976) and involved the production of AFB1 O-carboxymethyl-
hydroxylamine, followed by coupling of the activated aflatoxin molecule to amino-dextran
using carbodiimide coupling chemistry according to the method described by Hermanson
(1996).
Selection of antigen binders by panning. For selection, an immunotube was coated
overnight at 4°C with AFB1-BSA or AFB1-dextran (AFB1-Dex) diluted in PBS
(50–100 g ml–1). The tube was washed five times with PBS containing 0.05% (v/v). Tween
20 (PBST) and five times with PBS. This was then blocked with 4% (w/v) milk in PBS and
allowed to incubate for 1 h at 37°C. After this time the tube was again washed, and 1 ml of
phagemid particles was added to 3 ml of PBS, which in total contained 2% (w/v) milk. This
was allowed to incubate in the immunotube for 2 h at room temperature, gently shaking. After
washing (as before) bound phage was eluted from the tube by adding 800 l 0.1 M-glycine/
HCl, pH 2.2, for 10 min. This was then neutralized using 48 l of 2 M-Tris buffer. Phage were
then reinfected into E. coli. and grown on agar plates overnight.
Single colonies were selected from these plates and used to inoculate individual wells of
a 96-well cell culture plate containing 200 l 2 × TY containing 1% (v/v) glucose, 25 g ml–1
chloramphenicol and 30 g ml–1 tetracycline. Phage particle production was induced and
75 l of the supernatant produced from each clone was used for analysis of phage by direct
ELISA using an anti-M13 rabbit antibody to detect phage.
Positive individual clones were then inoculated into 5 ml of NE medium followed by
inducing phage particle production for analysis by competitive ELISA to characterize the
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clones specific for free toxin. This was carried out by coating AFB1-BSA conjugate onto a
microtitre (Nunc) plate, and adding the phage-scFvs to the plate in the presence of free toxin.
The bound phage-scFv’s were then detected using an anti-M13 rabbit antibody.
Insertion of VH-VL Fragment Into pAK 400 Plasmid Vector for Expression of
Soluble scFv Antibodies
Plasmids possessing the specific antibody genes were purified and digested with SfiI
followed by gel purification of the scFv fragment. This was followed by ligation into
previously digested pAK400 vector. Calcium-chloride-competent E. coli (JM 83) cells were
transformed with pAK400 vector harbouring the plasmid containing the heavy and light
chain genes for the scFv to AFB1.
For soluble expression, 20 to 200 ml expression medium (EM) (2 × TY containing
25 g ml–1 chloramphenicol) was inoculated with 200 l to 2 ml of preculture (JM83
harbouring the expression vector for AFB1), and allowed to grow at 37°C with shaking
(250 rpm) until the optical density at 600 nm had reached 0.5 AU. 1 mM-IPTG was added and
the culture allowed grow for 4 h at 24°C. The culture was centrifuged at 4000 rpm for 10 min
and the supernatant containing soluble scFv antibodies stored at 4°C. A 5 ml ProBond™
Resin (InVitrogen) column was used for the affinity purification of the scFvs. SDS-PAGE
and immuno blotting analysis were used to assess antibody purity, as well as confirm the
presence of the scFv in samples.
Competitive ELISA Using Soluble scFv Antibodies For Detection of Aflatoxin B1
Microtitre plates (Nunc Immunoplate Maxisorp, Gibco Ltd., Uxbridge, UK) were coated by
adding 100 l of AFB1-BSA conjugate dissolved in PBS to each well. The plates were
incubated overnight at 4°C. The plates were emptied and washed six times, three times with
PBST and three with PBS only. The plate was then blocked by addition of 100 l per well
of PBS containing 2% (w/v) milk powder and incubated for 1 h at 37°C (for both coating and
blocking of plates, incubation steps could also be carried out at 37°C for 1 h or 4°C
overnight).
The optimal dilution of the scFv antibodies, and the optimal conjugate concentration, for
use in competitive ELISA was determined by testing doubling dilutions of scFv against
decreasing concentrations of conjugate. This protocol was carried out in the absence of free
toxin. From the titre curves obtained, the antibody dilution that gave half the maximum
absorbance, and the lowest conjugate concentration that provided sufficiently high
absorbances was chosen.
Stock aflatoxin B1 solution was prepared at a concentration of 2 mg ml–1 in methanol and
diluted in PBS containing 5% (v/v) methanol to produce a set of standard solutions ranging
in concentration from 98–1560 ng ml–1. The plates were washed as before and 50 l of scFv
anti-AFB1 antibody was added into each well with 50 l of aflatoxin B1 standards. The plate
was incubated for 1 h at 37°C, followed by washing, and the addition of a 1/400 dilution of
anti-FLAG MAb. After incubation and washing, 100 l of horseradish peroxidase (HRP)-
conjugated-anti-mouse secondary antibody, diluted in PBS, was added to each well and
incubated for 1 h at 37°C. The plates were emptied and washed. 100 l of substrate
(0.4 mg ml–1 o-phenylenediamine (o-PD), in 0.05 M-phosphate citrate buffer, pH 5.0, and
0.4 mg ml–1 of urea hydrogen peroxide) was added into each well and incubated for 30 min
at 37°C. All absorbance values were measured on a Titertek Twinreader Plus plate reader at
an absorbance of 405 nm.
Measurement of Cross-reactions
Stock solutions of aflatoxin B2, M1, M2, G1, G2, B2a, and G2a were prepared in methanol and
diluted in PBS-5% (v/v) methanol with a range of concentrations from 31.25 to 500 ng ml–1.
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The assay was carried out in the same way as that for the competition ELISA except that
standards of the other aflatoxins were added to the plate with the anti-AFB1 antibody.
Preparation of Grain Matrix Samples
AFB1 samples in grain matrix were supplied as a gift from Mrs Sue Patel, RHM Technology
Ltd, The Lord Rank Centre, London Road, High Wycombe HP12 3QR, UK. A blank sample
of grain was extracted according to the method described by Scudamore and Patel (2000),
and then spiked with different concentrations of AFB1 according to the official AOAC
methods of analysis (Scott, 1995). The samples were then diluted to a final methanol
concentration of 5% (v/v).
Coupling Reaction of Aflatoxin B1-BSA to cm-Dextran Gel
The carboxymethylated dextran (cm-dextran) matrix was activated by mixing equal volumes
of 100 mM-NHS (N-hydroxysuccinimide), and 4 mM-EDC (N-ethyl-N- (dimethyl-amino-
propyl) carbodiimide hydrochloride) and injecting the mixture over the sensor chip surface
for 7 min at a flowrate of 5 l min–1. The interactant to be immobilized (concentration-
50–200 g ml–1) was dissolved in 10 mM-acetate buffer (at the required pH), and injected
over the surface for 20 min at a flow-rate of 2 l min–1. The unreacted sites on the sensor chip
surface were then capped by injection of 1 M-ethanolamine, pH 8.5, for 7 min.
Sample Preparation for Sensor Analysis
The scFv antibody was diluted in Hepes-buffered saline solution (HBS running buffer, pH
7.4). All buffers and solutions used were made up using ultrapure water, de-gassed and sterile
filtered.
Aflatoxin B1 Preparation for Use in Inhibitive Assay
A 2 mg ml–1 solution of free aflatoxin B1 was prepared in methanol. Standards were prepared
in PBS containing 5% (v/v) methanol, at concentrations ranging from 0.75 and 195 ng ml–1.
Each sample was incubated with an equal volume of a 1/4 dilution (final dilution-1/8) of anti-
aflatoxin scFv antibody for 10 min, and then passed over the surface of the chip. This was
carried out three times for each concentration. Regeneration of the surface of the chip was
carried out using 10 mM-NaOH.
RESULTS
Estimation of Mouse Titres
Two Balb/C mice were immunized with a commercially available AFB1-BSA conjugate. The
mice received an intra-peritoneal injection of the conjugate together with an equal volume of
Freund’s Complete adjuvant. Blood was drawn periodically to estimate the specific antibody
titre. The final titre for serum from mouse 1 was 1/153 600, while the final titre for serum
from mouse 2 was 1/76 800.
Amplification of Mouse Heavy and Light Chains Using PCR
The VL back primer mix (LB 1–17 and LB, representing a total of 131 variants) paired with
five VL forward primers (LF 1, 2, 4, 5 and LF) were used to amplify the VL domains. The
VH back mix (HB 1–19, representing a total of 94 variants) coupled with four VH forward
primers (HF 1–4) were used to amplify the VH domains. The domains were amplified from
a mixture of cDNA obtained from mice 1 and 2, respectively. Using the multiplex PCR
protocol, single amplified bands ranging from 375–402 bp for the VL, and 386–440 bp for
VH were achieved. Figure 1 shows typical bands obtained from the multiplex PCR reaction,
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where two batches of heavy chains were amplified, and one batch of light chain was
amplified.
Preparation of SOE-PCR Product and pAK 100 for Ligation Reaction
An SOE-PCR was carried out to anneal the heavy and light chains together to form an 800 bp
fragment. The product was digested with the restriction enzyme SfiI. Figure 2 shows a gel
photograph of the SOE-PCR product as well as the digested PCR product. Only a small
change in weight is observed between undigested and digested product. However, there is an
apparent difference between the two fragments. This showed the digestion was successful.
Figure 3 shows a gel photograph of the restriction enzyme digestion of pAK 100. It is easy
to differentiate between the cut vector (at approximately 4144 bp) and the tetracycline gene
(2101 bp), which was cut from the vector. The photograph also shows that a small amount of
the vector also remained uncut. However, there was sufficient vector digested to gel-purify
and use for the ligation reaction.
Production of AFB1-Dextran Conjugate
An AFB1-dextran conjugate was synthesized for use in the panning procedure, as it is
desirable to use more than one hapten-carrier conjugate when selecting for scFv antibodies
FIG. 1. Amplification of murine heavy (VH) and light chains (VL) from a mixture of DNA obtained from two
mice immunized with AFB1-BSA conjugate. Lane 1: 100 base pair (bp) ladder. Lanes 2–3: Amplified
heavy chains. Lane 4: Amplified light chains. In the case of the heavy chains, a sharp band with the
predicted size 375–402 bp was obtained, while for the light chain, a sharp band with the predicted
size 386–440 bp was obtained. These bands were observed as expected just below the 500 bp
fragment on the gel picture.
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to small molecules by phage display. The conjugate was produced, and its performance was
assessed using BIAcore analysis (data not shown). This was carried out by passing a
polyclonal anti-aflatoxin B1 antibody preparation over an immobilized AFB1-dextran
surface. Binding of the antibody to the dextran conjugate was observed, indicating that
conjugation of AFB1 to amino-dextran was successful. However, the antibody binding
response was low, indicating a low substitution ratio of the hapten to the amino-dextran.
Panning Procedure for the Detection of scFv Phage Display Antibodies
A phage display library consisting of 5 × 103 clones was produced by heat-pulse transforming
supercompetent E. coli cells with the ligated plasmid DNA. Three rounds of panning were
carried out on the library, using an AFB1-BSA conjugate (rounds 1 and 3), and an AFB1-
dextran conjugate (round 2). After each round of panning, phage titres were carried out in
order to assess the progress and efficacy of the panning procedure. 96 random bacterial
clones from each round of panning were also selected for analysis, and phage was produced
from them. These phage- displaying scFv antibodies were then analysed by phage ELISA for
recognition of AFB1-BSA conjugate. If it was found that the clones recognized the conjugate,
they were then analysed for recognition of free toxin. Table 1 shows a summary of the results
obtained from the three rounds of panning including phage titres, number of clones assayed
after each round, and the number that recognized free toxin.
Eight positive clones recognising AFB1-BSA conjugate were obtained after three rounds
of panning. Seven of the clones were analysed and tested for activity to free aflatoxin B1.
FIG. 2. Restriction enzyme digest of SOE-PCR product using SfiI. Lane 1: 100 bp ladder. Lane 2:
Undigested SOE product. Lane 3: Digested PCR product. Lane 4: Digested PCR product. Only a
minor change is observed between the digested and undigested bands, as only a small number of base
pairs are removed from the DNA fragment, and hence a small change in separation.
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This was carried out using three different concentrations of aflatoxin B1, 1, 50 and
100 g ml–1, respectively. Six of the clones showed recognition for free aflatoxin B1. Figure
4 shows this result. Non-specific interactions were minimal, as the clones did not recognize
BSA or milk-coated wells (data not shown).
Production of Soluble scFv Antibodies
Once it was confirmed that the positive clones recognized free AFB1, three of them were
chosen (B3, C4 and F4) for production as soluble scFv antibodies. In order to do this, the
TABLE 1. Data obtained from three panning rounds of an antibody phage-display library produced for the
detection of an scFv fragment to aflatoxin B1. The library was produced from RNA obtained from
a mouse that was pre-immunized with the AFB1-BSA conjugate prior to using the RNA
Conjugate
used for
panning
Phage
Titre
cfu ml–1
No. of
clones
assayed
No. of
clones
recognising
AFB1-BSA
conjugate
No. of
clones
recognising free
toxin
Phage Production – 2.5 × 109 96 0 0
Round 1 of panning AFB1-BSA 50 g ml–1 3.0 × 105 96 8 0
Round 2 of panning AFB1-Dextran 200 g ml–1 2.8 × 107 96 10 0
Round 3 of panning AFB1-BSA 50 g ml–1 2.4 × 107 96 7 6
FIG. 4. Competition phage-ELISA of seven clones selected after three rounds of panning for recognition to
free AFB1. All seven of the positives were analysed for recognition to free AFB1 by phage ELISA.
Six of the clones selected showed recognition for the free toxin over the range 1–100 g ml–1.
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bacteria containing the ‘positive’ plasmid DNA was grown on 5 ml scale and the DNA was
purified from the bacteria. The plasmid DNA was restriction enzyme digested using SfiI, and
electrophoresed on a low-melt agarose gel. The cut 800 bp fragment separated on the gel, and
was purified. The ‘positive’ scFv DNA was then ligated into pAK 400 and successfully
transformed into the non-suppressor E.coli strain JM 83. Stocks of the transformed bacteria
were made, and used to inoculate media for induction of scFv production.
Soluble scFv expression was induced on the transformed JM 83 cells as described by
Krebber et al. (1997). Culture supernatants and periplasmic lysates of the three clones were
analysed for soluble expression of the scFv fragments by non-competitive ELISA. The
culture supernatants and the periplasmic lysates from three clones were analysed (B3, C4 and
F4). From this, it was decided to work with only one clone from this stage, and therefore,
scFv clone-C4 was chosen for production of soluble scFv antibodies on a large scale and to
purify for further analysis. In order to confirm the presence of scFv antibody in the purified
samples, an immunoblot was carried out. Detection of the scFv was achieved using an anti-
FLAG antibody. Figure 5 shows a picture of the immuno blot. It can be seen that the 32 KDa
fragment is quite clear and specific in the purified sample. However, it cannot be seen in the
culture supernatant sample, as it may not be concentrated sufficiently.
FIG. 5. Immunoblot analysis of IMAC-purification of C4 clone. Lanes 1 and 4: Coloured molecular weight
markers. Lane 2: IMAC-purified supernatant. Lane 3: Supernatant. The 32 KDa protein fragment is
more apparent in the purified fraction than the supernatant, mainly because the purified fractions
were concentrated five-fold after the purification procedure.
ELISA Analysis of Soluble scFv Antibodies
A checkerboard ELISA was carried out in order to determine the optimal antibody dilution
and conjugate concentration for use in competitive ELISA. From this, it was decided to use
a 1/4 dilution of antibody in the competition ELISA, with a conjugate concentration of
12.5 g ml–1. The competition ELISA produced a linear range of detection for the scFv
antibody between 98 and 1560 ng ml–1 (data not shown), and was found to be reproducible
over three days.
Cross-reactivity studies were also carried out on the scFv antibody to seven other
structurally related aflatoxins. Standard curves for each of the aflatoxins were produced, and
the results were normalized and plotted. The slope of the line of the standard curve for each
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toxin was expressed as a percentage of the slope of the line for binding to AFB1. The
antibody showed a high level of cross-reaction to the structurally related aflatoxins, with the
percentage of cross-reactivity for each shown in Table 2.
Background Development of Antibody-based Assay on BIAcore
After confirmation that the scFv antibody recognized free toxin in ELISA, the development
of an inhibition surface plasmon resonance-based assay was evaluated. Non-specific binding
of the scFv antibody was examined. The AFB1-BSA conjugate, and BSA were immobilized
onto separate sensor surfaces. There was negligible non-specific binding of the scFv to the
BSA protein compared to AFB1-BSA, or to the cm-dextran surface.
Efficiency of Regeneration
The scFv antibody gave an excellent binding response to aflatoxin B1. A 1/8 dilution of the
antibody was found to be sufficient to achieve significant binding to the immobilized
conjugate surface. Regeneration studies, using a 1/8 dilution in HBS of scFv anti-AFB1
antibody showed that it was easily regenerated from the AFB1-BSA immobilized surface
using a 1 min pulse of 10 mM-NaOH. This completely removed all bound scFv antibody after
each binding-regeneration pulse. Figure 6 shows a graph of the reproducibility of
regeneration for the scFv antibody over 50 regeneration cycles. Binding of the scFv antibody
to the conjugate surface was highly reproducible, with approximately 250 RU of antibody
binding to the surface each time. The regeneration solution (10 mM-NaOH) did not affect the
binding throughout the regeneration study.
BIAcore Assay
An inhibition assay was then developed by immobilising 50 g ml–1 of aflatoxin B1-BSA
conjugate prepared in 10 mM-sodium acetate, pH 3.9. Standards of free aflatoxin were
prepared ranging in concentration from 0 to 195 ng ml–1. Each sample was incubated with an
equal volume of a 1/4 dilution (to ensure a final dilution of 1/8) of the scFv for 1 h a 37°C,
and then randomly passed over the surface of the chip for each concentration three times. The
binding of antibody to the surface of the chip was inversely proportional to the amount of free
aflatoxin in solution. Figure 7 shows the relationship between the number of Response Units
bound and the concentration of free aflatoxin B1. The intra-day variability assay had a range
of detection between 3 and 195 ng ml–1. Inter-day variation was also carried out with the
TABLE 2. Cross-reactions of scFv anti-AFB1 antibody (C4) observed to
seven other aflatoxins. Standard curves were produced for
each of the aflatoxins in the same way as that for AFB1. Each
concentration for each point on the standard curve was
assayed in triplicate and the means plotted and normalized in
order to construct standard curves
Aflatoxin scFv % Cross-reactivity
B1 100
B2 53
G1 76
G2 68
M1 50
M2 23
B2a 18
G2a 22
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FIG. 6. Graph showing the reproducibility of regeneration of a sensor chip immobilised with AFB1-BSA on
the surface. Fifty consecutive regeneration cycles of a 3 min binding pulse of scFv anti-AFB1 were
carried out. This was followed by a 1 min injection of 10 mM-NaOH as the regeneration solution.
This completely removed all of the bound antibody after each binding cycle, which resulted in highly
reproducible binding cycles, as no significant decrease in the measured binding response over the
course of the regeneration study was observed.
FIG. 7. Inter-day assay curve for AFB1 in PBS using scFv anti-AFB1 antibody. The range of detection for
the antibody was between 3 and 195 ng ml–1. The calibration plot was constructed using
BIAevaluation 3.1 software package. The results shown are the average of triplicate results.
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assay being reproducible over three days between 3 and 195 ng ml–1. Table 3 shows the
coefficients of variation for the inter-day assay.
Detection of AFB1 in Spiked Grain Samples
Spiked grain samples were prepared as described in materials and methods, and applied in an
inhibition assay for the scFv anti-AFB1 antibody in the same manner as outlined previously.
TABLE 3. Inter-day coefficients of variation for scFv anti-AFB1 antibody. Three sets of eight standards were
run on three different days, and the measured binding responses were used to calculate the
normalised binding response values. From these the CVs were calculated as the standard
deviation expressed as a percentage of the mean normalized values for each standard
Aflatoxin B1
concentration
(ng ml–1)
Calculated
mean ± SD
(R/R0)
Coefficient
of variation
(%)
195 0.09 ± 0.01 11.06
98 0.14 ± 0.01 12.39
48 0.27 ± 0.05 19.95
24 0.53 ± 0.02 4.01
12 0.79 ± 0.02 3.5
6 0.89 ± 0.03 3.95
3 0.96 ± 0.03 3.35
FIG. 8. Inter-day assay curve for AFB1 in grain samples spiked with AFB1 using scFv anti-AFB1 antibody.
The range of detection for the antibody was between 0.75 and 48 ng ml–1. The calibration plot was
constructed using BIAevaluation 3.1 software package. The results shown are the average of
triplicate results.
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Regeneration was also carried out using 10 mM-NaOH. The intra-day assay curve for the
range detection for the scFv antibody was between 0.75 and 48 ng ml–1, with percentage CVs
between 0.1 and 16.5%. Inter-day variation studies were also carried out by running the assay
on three separate days, normalising the results, and calculating the percentage CVs between
the assays. Figure 8 shows the inter-day assay curve with a range of detection for the scFv
antibody between 0.75 and 48 ng ml–1. Table 4 shows the percentage CVs which varied
between 3.7 and 11.8%.
DISCUSSION
Balb/c mice were immunized with an AFB1-BSA conjugate, and once a sufficiently high
enough specific antibody titre was obtained, the spleen was removed from the mice, and the
RNA extracted from it.
Amplification of the heavy and light chains was carried out using the extended primer mix,
which incorporated all of the mouse VH, V, and V sequences collected in the Kabat data
base (Kabat et al., 1991). It also combined the extended primer sets described by
Kettleborough et al. (1993), Ørum et al. (1993), and Zhou et al. (1994). This ensured that a
larger repertoire of DNA coding for the mouse heavy and light chains was effectively and
specifically amplified, and as a result a larger population of antibodies available for selection
during the screening process. It can be seen (Figure 1) that the heavy and light chains were
specifically amplified, using an annealing temperature of 63°C. Approximately 10 ng of each
of the VH and VL was used for the SOE-PCR. This produced an 800 bp fragment, as the
heavy and light chains are approximately 400 bp long each.
Both the SOE-PCR product and the vector pAK 100 had to be restriction enzyme- digested
prior to the ligation step. SfiI was the restriction enzyme used, as it cuts two sites at once on
a piece of DNA. It is also useful, as the sites at which it cuts at are quite rare in antibody
sequences, and therefore, it eliminates the possibility of internal digestion, and incorrect
sequence lengths. Digestion of the SOE product results in a very small change in weight of
the piece of DNA. It is therefore quite difficult to differentiate between cut and uncut DNA.
In order to aid the visual differentiation, the samples were electrophoresed on a 2–2.5%
agarose gel, which improved the separation of the fragments. Figure 2 shows an agarose gel
of digested and undigested fragment, and it is just possible to differentiate between the two
fragments on the gel, indicating the reaction was successful. Digestion of the pAK 100 vector
was visually easier to differentiate, as the cut tetracycline cassette is 2101 bp in length. This
was easily visualized on the gel (Figure 3). It can also be seen on the gel that a certain amount
TABLE 4. Inter-day coefficients of variation in grain samples spiked with AFB1 using scFv anti-AFB1
antibody. Three sets of eight standards were run on three different days, and the measured binding
responses were used to calculate the normalised binding response values. From these the CVs
were calculated as the standard deviation expressed as a percentage of the mean normalized
values for each standard
Aflatoxin B1
concentration
(ng ml–1)
Calculated
mean ± SD
(R/R0)
Coefficient
of variation
(%)
48.0 0.19 ± 0.007 4.13
24.0 0.24 ± 0.01 7.47
12.0 0.33 ± 0.04 11.83
6.0 0.44 ± 0.01 4.06
3.0 0.67 ± 0.02 3.58
1.5 0.84 ± 0.03 4.63
0.75 0.93 ± 0.03 3.75
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of vector remained uncut. Possibly there was not enough SfiI to digest all-the vector present
in the sample. However, it is more favourable to have ‘too-little’ enzyme rather than ‘too-
much’, especially in the case of SfiI. In reactions, with the enzyme in excess of DNA sites,
each site becomes loaded with SfiI tetramer, and thus preventing the protein from binding the
two sites necessary for full activity. Hence, it is easier to re-digest a sample to obtain
complete digestion, rather than add too much initially, and not achieve any or sufficient
digestion.
Once both the vector and the SOE product were digested, they were ligated and
transformed into supercompetent E. coli XL-1 blue cells. An antibody phage display library
consisting of 5 × 103 clones was produced. This library would be considered as very small
in size, as it is possible to generate libraries consisting of 107 or 108 clones. However, given
the fact that the library was produced from RNA that originated from a pre-immunized
mouse, it was decided to attempt panning from the library, rather-than repeating the
transformation procedure to produce a larger library.
In order to select for small haptens from a phage display library it is optimal to use more
than one hapten–protein conjugate. Therefore, a second AFB1 conjugate needed to be
synthesized. Amino-dextran was chosen as the carrier molecule, as previously, it has been
shown to yield low background values in ELISA (Xiao et al., 1995). This feature of amino-
dextran is optimal for use in the panning procedure, as it is necessary to keep background
signals to a minimum to ensure a non-biased selection for positive clones recognising free
hapten.
Three rounds of panning were carried out on the library using two different hapten-carrier
conjugates. Round 1 of panning was carried out using an AFB1-BSA conjugate coated onto
an immunotube at 50 g ml–1, which yielded a phage titre of 3.0 × 105 cfu ml–1 of phage. For
round two of panning, a different hapten-carrier conjugate was used, as it was desirable to
switch the carrier molecule for the second round. This ensured that non-specific phage
recognising the protein (from the round 1 conjugate) were not re-selected and amplified.
Instead, only phage generally recognising the hapten were selected for, thus increasing the
chances of selecting and amplifying a specific phage-antibody to the hapten. As a result of
this, AFB1-dextran was used for round 2 of panning. A high concentration of 200 g ml–1 was
used to coat the immunotube, due to the low substitution ratio on the conjugate. This yielded
a phage titre of 2.8 × 107 cfu ml–1, which was higher than the titre obtained from round 1. 96
random clones were picked from both rounds one and two of panning and phage was
produced from them. These phage clones were then analysed for recognition to AFB1-BSA
conjugate, and subsequently, if they were positive were analysed for recognition to free
AFB1. However, results from both rounds of panning yielded no clones that recognized free
AFB1. Therefore, a third round of panning was carried out.
AFB1-BSA conjugate was used for round 3, as the previous round ensured that non-
specific ‘BSA-binding’ phage antibodies were removed from the selection process. As the
number of rounds of panning increase, the selection for a specific phage-antibody becomes
more stringent, as each round (providing different conjugates are used) ensures a reduction
in the amount of non-specific phage, and greater amplification of specific phage. Round 3
gave a phage titre of 2.4 × 107 cfu ml–1, which was slightly less than that obtained from round
2. 96 random clones were picked and assayed for selection to AFB1-BSA conjugate. Seven
clones showed good recognition for the conjugate, with significantly lower background
levels compared to the round 2 ELISA (data not shown). The seven clones were then assayed
for recognition to free AFB1, in which six showed recognition over the range of
1–50 g ml–1. The panning process was highly successful, as selection of phage antibodies
to small haptens is generally quite difficult.
It has been mentioned elsewhere (Moghaddam et al., 2001) that selection of a large
number of antibodies to low molecular weight haptens conjugated to BSA or biotinylated can
often be unsuccessful for the detection of antibodies that bind the non-derivatised form of the
hapten. Moghaddam et al. (2001) screened for phage display scFv antibodies to AFB1 from
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non-immunized human phage libraries, as well as semi-synthetic phage libraries. It was
found that a large percentage of the antibodies isolated from the non-immunized (human)
library specifically bound AFB1-BSA conjugate but did not bind free AFB1, and if so, had
at least 100-times less affinity than for the BSA conjugated form. However, they did find that
a percentage of the scFv antibodies that bound to both free toxin and conjugate dramatically
increased, when free AFB1 was used for elution of phage from AFB1-BSA during the elution
step of the panning. With respect to the semi-synthetic library, after three rounds of panning
using the same conjugate, antibodies with high affinities to free AFB1 were detected. This is
a similar finding to what is presented in this paper, except that two different conjugates were
used. However, they used AFB1 for elution of the phage from the immunotube, which may
have increased the stringency of the procedure.
Three of the clones (B3, C4, and F4) that recognized free AFB1 were then selected for
expression as soluble scFv antibodies. Restriction enzyme digestion of the pAK 100 plasmid
containing the ‘positive’ scFv fragment was successfully carried out, as was digestion of the
high expression vector pAK 400, which contains the enhanced Shine-Dalgarno sequence.
Ligation of the scFv fragments into the plasmid was carried out and these were then
transformed into the non-suppressor E. coli strain JM 83, which enhances soluble scFv
expression. Analysis of the periplasmic lysates and the culture supernatants was carried out
by ELISA. It was decided to concentrate on working with clone C4, as it demonstrated a
good level of expression into culture supernatant and, therefore, a quicker route to obtaining
and purifying the scFvs.
After scFv antibodies were produced in culture supernatant, they were concentrated five-
fold and then purified using ProBond(resin, which is an IMAC-based column (Janknecht et
al., 1989). Immunoblot analysis was also carried out to identify the scFv antibodies. Figure
5 shows the immunoblot, where a single band can be observed for purified sample indicating
the presence of scFv antibodies. No significant band was observed in the culture supernatant.
This is probably because the sample was not sufficiently concentrated for the anti-FLAG
antibody to detect it in the blot.
It was important to initially optimize the concentration of AFB1-conjugate and scFv
antibody for use in a competitive ELISA. A checkerboard ELISA was therefore carried out
for the scFv antibody. The antibody dilution used was 1/4 with a conjugate loading density
of 12.5 g ml–1 for the assay. A competition ELISA was optimized for the scFv antibody
using these parameters. The assay was relatively sensitive, with a limit of detection of 98
ng ml–1. It was also reproducible over three different days with inter-day CVs below 11.9%.
Yuan et al. (1997) produced scFv antibodies to the mycotoxin zearalenone, and found that the
soluble antibodies could detect as little as 14 ng ml–1 for 50% inhibition of binding. The scFv
antibodies produced by Moghaddam et al. (2001) could detect as little as 14 M-AFB1 in
solution. It is clear that these antibodies are more sensitive than the scFv produced here.
However, it is thought that the assay could be further optimized if a more sensitive anti-
FLAG antibody could be obtained. Enzyme-labelling the anti-FLAG antibody could also
improve the sensitivity of the assay, as it would reduce the number of incubation steps, as
well as reduce the probability of the enzyme-labelled anti-species antibody reducing the
sensitivity. Cross-reactivity studies were also carried out on the scFv antibody. Table 2 shows
the results of the studies, where the scFv antibody showed high degrees of cross-reactivity,
especially to AFG1 > AFG2 > AFB2 > M1 (in decreasing order). Moghaddam et al. (2001)
analysed their scFv antibodies for cross reactivity using BIAcore. They found that the
antibody was able to bind as effectively to AFG1 as AFB1. This is a similar finding to what
was observed with the scFv antibody reported here. However, their scFv did not show any
recognition for AFM1 or AFM2. It is favourable to produce specific antibodies for a particular
hapten, but it could be advantageous from a regulatory viewpoint to apply this scFv antibody
for the detection of total aflatoxin concentration in a sample.
When designing SPR-based immunoassays, an important factor in their design is the
regenerability of the sensor-chip surface in order to carry out multiple analyses. Ideally it
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should be possible to carry out 50 or more regeneration cycles on a given immobilized
surface, and ligand-binding capacity should be maintained within 20% of positive control
values (Wong et al., 1997). Regeneration studies were carried out on the scFv anti-AFB1
antibody for binding to an immobilized AFB1-BSA conjugate surface. They showed that it
was easily regenerated from the AFB1-BSA immobilized surface using a 1 min pulse of
10 mM-NaOH. The binding responses were highly consistent throughout the regeneration
study with a variation of binding of approximately 8%. There was no decrease in measured
binding response throughout the study (i.e. cycle 1 = 244.7, cycle 49 = 244.3). The was
probably due to pre-treatment of the conjugate surface with 20 1 min pulses of 10 mM-
NaOH, which would have removed any loosely bound conjugate from the immobilized
surface. As a result, when scFv antibody was injected over the conjugate surface, no leeching
of scFv antibody-conjugate complex from the surface was observed. Therefore, a decrease in
binding signal was not observed throughout the regeneration study, and the binding-
regeneration pulses were true to the signal observed. The scFv antibody also displayed no
non-specific binding to BSA or the CM-dextran gel surface. This is probably due to the fact
that it is monoclonal in nature, and therefore recognizes only one epitope, which is present
of the AFB1 molecule.
After optimising the binding capacity and the degree of non-specific binding of the scFv
antibody, the working range of detection of the BIAcore-based assay was then evaluated. The
limit of quantification for the assay was 3 ng ml–1, with a range of detection between 3 and
195 ng ml–1 (Figure 7). The intra-day CVs were between 0.16 and 1.03% (data not shown),
while the inter-day CVs were between 3.35 and 19.95% (Table 3).
It can be seen that the scFv showed a high level of sensitivity for the detection of AFB1 with
a limit of detection of 3 ng ml–1. The assay was also reproducible with good levels of precision,
and reproducibility. However, some of the CVs were above 10%. The scFv showed very high
intra-day degrees of precision with only the highest CV at 1.03%. This was probably a result of
stringent pre-treatment of the immobilized surface prior to assay analysis, as well as that it was
a very mild regeneration solution. This in turn gave rise to accurate binding responses during a
given assay. The CVs for the scFv inter-day assay were slightly higher at certain points,
indicating only a moderate degree of reproducibility. Findlay et al. (2000) say that since the
basis of immunoassays is the antibody–antigen interaction, they may be less precise than
chromatographic techniques, and as a result, existing methods with respect to degrees of assay
precision are too stringent. They recommend minimal acceptance limits of 20% (25% at the
limits of quantification) for precision profiles. Wong et al. (1997) describe the validation of an
assay using BIAcore 2000 for the detection and quantification of humanized MAb in mouse
serum. They examined and number of variables within the assay including degrees of
precision, accuracy, specificity and sensitivity. They state that their acceptance criteria for
validation is applicable to all biosensor-based immunoassays used to determine the
concentration of an analyte, and indicate that results should be quantitated within 20% CV as a
measure of precision. When considering these requirements, the assay presented is within the
required acceptance limits and can be deemed reproducible.
The scFv antibody was also used for the detection of AFB1 in spiked grain samples, using
BIAcore. It was more sensitive for the detection of AFB1 in grain samples compared to the
model PBS assay, with a detection range between 0.75 and 48 ng ml–1. The assay also showed
good levels of precision (intra-day CVs: 0.17–16.53%) and reproducibility (inter-day CVs:
3.75–11.83%). Linskens et al. (1992) state that low concentrations of methanol extraction
solvent can enhance the performance of some assays, and hence this may give a possible
reason for the scFv antibody being more sensitive for the detection of AFB1 in grain samples.
Van der Gaag et al. (1999) developed a BIAcore-based inhibition assay for the detection of
AFB1 in spiked grain samples. They used a commercially available MAb, and directly
immobilized AFB1 onto the sensor-chip surface. The assay could detect levels as low as
0.2 ppb (ng ml–1). The assay developed here is capable of detecting as low as the EU
maximum residue level set for AFB1 (3 ppb [ng g–1]) in grain samples.
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CONCLUSIONS
The production of an antigen-specific antibody phage display library from the RNA obtained
from a mouse pre-immunized with AFB1-BSA conjugate was successful. The stringency of
the panning procedures using two toxin-carrier conjugates sequentially reduced the number
of non-specific phage after each round of panning. It resulted in the highly successful
isolation of seven phage display clones, six of them recognising free AFB1 in solution.
Soluble production of one of the scFv antibody clones was induced using the high expression
vector pAK 400. A competition ELISA was optimized using this scFv antibody. An SPR-
based inhibition immunoassay was also developed. The assay was then applied for the
detection of AFB1 in spiked grain samples. It showed a high level of sensitivity, being
capable of detecting AFB1 below the maximum residue levels allowed by the EU. The
application of these antibodies for use in a ‘on-line’ antibody-based biosensor could have a
significant impact on routine surveillance and analysis of agri-food materials.
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